KAT6 INHIBITORS

Claims

This document describes compounds used as KAT6 inhibitors and pharmaceutical compositions comprising these compounds. It also describes a method for treating a disorder or disease that responds to the inhibition of KAT6 activity in a subject. In one embodiment, the compounds have formula (1), or a pharmaceutically acceptable salt thereof, a deuterated analogue thereof, or an N-oxide thereof, or a tautomer thereof, wherein the values ​​for the variables (e.g., ring B, A1, A2, A3, A4, A5, X1, L, R62, R63, R64, R7, and n) are as described herein.